Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of NRP2 mRNA | increases expression | 19933214
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of NRP2 mRNA | affects expression | 16483693
|
D001104 |
Arbutin |
Arbutin results in increased expression of NRP2 mRNA | increases expression | 17103032
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in decreased expression of NRP2 mRNA | decreases expression | 18687144
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of NRP2 mRNA | affects expression | 17484886
|
D002713 |
Chlorine |
[Ozone co-treated with Chlorine] results in increased expression of NRP2 mRNA | affects cotreatment|increases expression | 18636392
|
D002117 |
Calcitriol |
Calcitriol results in decreased expression of NRP2 mRNA | decreases expression | 16002434
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of NRP2 mRNA | increases expression | 16002434
|
D007608 |
Kainic Acid |
NRP2 protein affects the susceptibility to Kainic Acid | affects response to substance | 18657176
|
C064769 |
N-acetylsphingosine |
sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in decreased expression of NRP2 mRNA] | decreases expression|decreases reaction | 15741222
|
C029938 |
nickel sulfate |
nickel sulfate results in increased expression of NRP2 mRNA | increases expression | 16780908
|
D010126 |
Ozone |
[Ozone co-treated with Chlorine] results in increased expression of NRP2 mRNA | affects cotreatment|increases expression | 18636392
|
D010433 |
Pentylenetetrazole |
NRP2 protein affects the susceptibility to Pentylenetetrazole | affects response to substance | 18657176
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of NRP2 mRNA | increases expression | 18301758
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of NRP2 mRNA | increases expression | 12832660
|
C025299 |
polyphenols |
polyphenols results in decreased expression of NRP2 mRNA | decreases expression | 16293270
|
C035988 |
procymidone |
procymidone results in decreased expression of NRP2 mRNA | decreases expression | 15686871
|
C410733 |
scriptaid |
scriptaid affects the expression of NRP2 mRNA | affects expression | 18813790
|
C060506 |
sphingosine 1-phosphate |
sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in decreased expression of NRP2 mRNA] | decreases expression|decreases reaction | 15741222
|
C060506 |
sphingosine 1-phosphate |
sphingosine 1-phosphate inhibits the reaction [Thalidomide results in decreased expression of NRP2 mRNA] | decreases expression|decreases reaction | 15741222
|
D013792 |
Thalidomide |
sphingosine 1-phosphate inhibits the reaction [Thalidomide results in decreased expression of NRP2 mRNA] | decreases expression|decreases reaction | 15741222
|
C025643 |
vinclozolin |
vinclozolin affects the expression of NRP2 mRNA | affects expression | 19015723
|
C025643 |
vinclozolin |
vinclozolin results in decreased expression of NRP2 mRNA | decreases expression | 15686871
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Thalidomide |
4.50 | 8333272 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.50 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
Chlorine |
15.00 | 20601635 |
MESH:D055371 |
Acute Lung Injury |
|
nickel sulfate |
15.00 | 12718980 16100012 19131640 11954676 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
15.00 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.42 | 16434500 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
2.42 | 15513908 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
Thalidomide |
4.31 | 16510725 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.58 | 19015723 |
MESH:D001169 |
Arthritis, Experimental |
|
Thalidomide |
4.18 | 9598899 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.54 | 15570426 |
MESH:D001249 |
Asthma |
|
Ozone |
2.62 | 17854713 16373670 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 17427189 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.08 | 19483382 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
2.62 | 11237771 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.62 | 18417511 19059883 15516495 14754758 18315731 17626835 16777450 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.68 | 16183385 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.72 | 16192424 16011737 16050911 18705752 3786805 16124888 15673190 10355542 15721981 16097048 16227642 15700767 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
3.42 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Thalidomide |
3.42 | 16313753 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
2.60 | 11237771 |
MESH:D018281 |
Cholangiocarcinoma |
|
Thalidomide |
4.81 | 18291259 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.77 | 19176532 |
MESH:D003092 |
Colitis |
|
Thalidomide |
4.79 | 16680017 |
MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
2.66 | 16293270 |
MESH:D016510 |
Corneal Neovascularization |
|
Thalidomide |
5.51 | 9301478 |
MESH:D003389 |
Cranial Nerve Diseases |
|
Thalidomide |
6.25 | 9200351 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Thalidomide |
2.96 | 9200351 |
MESH:D003424 |
Crohn Disease |
|
Thalidomide |
4.13 | 16078585 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.28 | 14966744 |
MESH:D003643 |
Death |
|
Pentylenetetrazole |
6.68 | 6431079 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
nickel sulfate |
3.61 | 16823706 16780908 11298694 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.39 | 18249437 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
4.10 | 15027814 4309450 6884620 19085960 3786805 7440962 6623471 16177239 15998439 9327722 7179309 15968718 21278145 16227642 10915739 2869522 3732212 17522070 10092053 11566570 7120509 19336974 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
4.10 | 19370779 |
MESH:D004417 |
Dyspnea |
|
Chlorine |
4.57 | 20016425 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.42 | 12083418 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
3.87 | 15138306 |
MESH:D004832 |
Epilepsy, Absence |
|
Pentylenetetrazole |
5.58 | 6426943 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
7.47 | 15959796 12795759 12631006 16239168 17595544 61145 16045604 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
7.47 | 20131406 19236843 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
3.39 | 18705752 |
MESH:D005739 |
Gas Poisoning |
|
Chlorine |
4.95 | 20016425 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.87 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.24 | 16417039 |
MESH:D005871 |
Giant Lymph Node Hyperplasia |
|
Thalidomide |
6.25 | 12701121 |
MESH:D005910 |
Glioma |
|
Thalidomide |
3.79 | 16327979 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.50 | 20558911 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.53 | 19110552 19900420 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
2.93 | 18467677 16221962 19772884 19176532 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.47 | 16899240 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.12 | 20558911 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.02 | 15338365 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
3.00 | 16467254 |
MESH:D007249 |
Inflammation |
|
polyphenols |
5.66 | 16366677 |
MESH:D007249 |
Inflammation |
|
Thalidomide |
5.66 | 16134734 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.59 | 16306350 |
MESH:D007898 |
Leishmaniasis, Visceral |
|
Thalidomide |
4.29 | 16514283 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Thalidomide |
3.21 | 18720364 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.67 | 16417039 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Thalidomide |
4.41 | 10473037 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
6.92 | 17334410 17157831 11408273 17174718 21278145 11903743 16239168 16221502 16943688 |
MESH:D008103 |
Liver Cirrhosis |
|
Thalidomide |
6.92 | 17174718 16943688 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
3.57 | 16136751 15052691 12898905 17721639 17698563 17708605 17922224 18210741 17481882 14724832 17714472 18418968 18054572 15123356 17869086 17565644 18277467 18339082 12609069 11481614 17557913 15338365 14716833 17766677 18472094 15650968 16033810 18481824 18420326 12958196 16015684 10355542 12445418 18279442 16011737 18166357 14748882 15730626 18395914 18705752 18376398 20821823 15931870 17900296 18251166 15876570 12649538 18156304 18263696 16097048 15959796 13678700 15370692 17631135 12546737 15673190 14512876 18187930 18412020 12445421 17823541 12667390 12666154 15057751 14716496 12632514 15818738 17640975 18472332 12632512 15925388 15362042 17976157 15893842 18006644 17805973 16638106 18429990 18395095 18205269 14620537 17525996 12389079 12741479 16248980 16116963 17944888 16027843 18317297 16192424 15996030 12586293 17761835 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.57 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Thalidomide |
3.57 | 15465738 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
4.27 | 15720792 17285989 16964402 16246199 15830285 |
MESH:D008107 |
Liver Diseases |
|
polyphenols |
4.27 | 16698588 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.10 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.63 | 14706259 16899240 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
4.35 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.35 | 16377806 20007298 15890375 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
2.57 | 12014681 15583823 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
3.33 | 19066396 8266340 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
9.03 | 17365036 |
MESH:D055370 |
Lung Injury |
|
Ozone |
9.03 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
2.09 | 8597069 7614698 |
MESH:D008545 |
Melanoma |
|
Thalidomide |
3.08 | 16098027 12829675 17089043 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
3.16 | 16966607 16166281 18303189 |
MESH:D008679 |
Metaplasia |
|
Ozone |
5.05 | 10496685 |
MESH:D009101 |
Multiple Myeloma |
|
Thalidomide |
4.14 | 19112201 15920492 15741222 15867202 15744524 17168659 15939924 19112817 16445831 19372569 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.44 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Thalidomide |
4.19 | 18720364 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.11 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.89 | 16411023 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
1.92 | 17405874 |
MESH:D009421 |
Nervous System Malformations |
|
Thalidomide |
4.86 | 16859833 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.80 | 20558911 |
MESH:D010051 |
Ovarian Neoplasms |
|
Thalidomide |
3.47 | 16288038 |
MESH:D010291 |
Paresis |
|
Thalidomide |
6.25 | 9200351 |
MESH:D010538 |
Peritonitis |
|
Ozone |
4.07 | 16369182 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.83 | 10923243 |
MESH:D011014 |
Pneumonia |
|
Ozone |
4.33 | 18381685 18929643 18007984 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Thalidomide |
4.19 | 17031469 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
3.84 | 19015723 18220299 18042343 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.87 | 18220299 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.72 | 15572423 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
3.81 | 15754350 18247401 16644109 16289102 12479363 |
MESH:D011471 |
Prostatic Neoplasms |
|
Thalidomide |
3.81 | 16729912 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.87 | 18629315 |
MESH:D011536 |
Prurigo |
|
Thalidomide |
6.25 | 12755975 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
3.00 | 17365031 17322281 17975199 15814490 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.35 | 19058328 |
MESH:D012120 |
Respiration Disorders |
|
Chlorine |
5.16 | 18579056 |
MESH:D019873 |
Schnitzler Syndrome |
|
Thalidomide |
5.88 | 16096327 |
MESH:D012640 |
Seizures |
marker/mechanism |
|
| 18657176 |
MESH:D012640 |
Seizures |
|
Kainic Acid |
7.22 | 17827730 14637104 10686065 1641125 18657176 16336964 15686955 19414003 19186208 |
MESH:D012640 |
Seizures |
|
Pentylenetetrazole |
7.22 | 18164287 18657176 16054440 8954991 15475178 3037702 6431079 3352866 19660546 2616065 |
MESH:D012893 |
Sleep Disorders |
|
Kainic Acid |
5.63 | 19414003 |
MESH:D013276 |
Stomach Ulcer |
|
Thalidomide |
4.11 | 15138204 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
5.20 | 17997062 |
MESH:D014652 |
Vascular Diseases |
|
Thalidomide |
5.42 | 15741222 |
MESH:D014947 |
Wounds and Injuries |
|
sphingosine 1-phosphate |
5.40 | 15541073 |